期刊文献+

沙利度胺抗肿瘤血管生成的临床研究进展 被引量:6

下载PDF
导出
摘要 沙利度胺抗肿瘤血管生成的作用已经日渐明确,临床研究证实,沙利度胺对多发性骨髓瘤、急性髓系白血病、子宫肿瘤、前列腺癌等有一定的抗肿瘤血管生成作用,而对其它肿瘤的作用也在进一步研究中。本文对沙利度胺抗肿瘤血管生成的临床研究进展做一综述。
出处 《现代肿瘤医学》 CAS 2009年第5期972-974,共3页 Journal of Modern Oncology
  • 相关文献

参考文献24

  • 1Gelati M, Corsini E, Frigerio S, et al. Effects of thalidomide on parameters involved in angiogenesis : art in vitro study [ J]. J Neurooncol,2003,64(3) :193 -201.
  • 2Fujita K, Asami Y, Tanaka K, et al. Anti -angiogenic effects of thalidomide:expression of apoptosis - inducible active - caspase - 3 in a three - dimensional collagen gel culture of aorta [ J]. Histochem Cell Biol,2004,122 (1) :27 -33.
  • 3Komorowski J,Jerczynska H, Siejka A, et al. Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA. hy 926 cells [ J ]. Life Sei ,2006,78 (22) :2558 - 2563.
  • 4Sauer H, Gunther J, Hescheler J, et al. Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals [J]. Am J Pathol,2000,156(1) :151 -158.
  • 5Lentzsch S, LeBlanc R, Podar K, et al. Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan ceils and angiogenesis in vivo [J]. Leukemia,2003,17(1) :41 -44.
  • 6Downs LS Jr, Rogers LM,Yokoyama Y, et al. Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer [J]. Gynecol Oncol,2005,98(2) :203 -210.
  • 7Kumar S, Witzig TE, Dispenzieri A, et al. Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma [ J ]. Leukemia,2004,18 ( 3 ) :624 - 627.
  • 8Hatjiharissi E ,Terpos E, Papaioannou M, et al. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro - vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma [ J]. Hematol Oncol,2004,22 (4) : 159 - 168.
  • 9Kumar S, Witzig TE, Dispenzieri A, et al. Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma [J]. Leukemia,2004,18 ( 5 ) :624 - 627.
  • 10Mileshkin L, Honemann D, Gambell P, et al. Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines, angiogenic markers, mast cells and marrow CD57^+ cytotoxic T cells as predictors of outcome [J]. Haematologica,2007,92 (6) : 1075 - 1082.

同被引文献90

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部